Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $5.91 and last traded at $5.21, with a volume of 1159063 shares. The stock had previously closed at $5.65.
Analysts Set New Price Targets
Separately, Needham & Company LLC lifted their price target on Curaleaf from $4.25 to $5.25 and gave the stock a "buy" rating in a research report on Thursday, March 7th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $6.19.
Check Out Our Latest Stock Analysis on Curaleaf
Curaleaf Trading Up 5.0 %
The stock has a 50-day simple moving average of $5.03 and a two-hundred day simple moving average of $4.31. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.41 and a current ratio of 0.85. The firm has a market cap of $3.63 billion, a PE ratio of -14.49 and a beta of 1.77.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, March 6th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.04. The business had revenue of $345.27 million during the quarter, compared to analyst estimates of $336.64 million. Curaleaf had a negative return on equity of 12.93% and a negative net margin of 20.77%. As a group, sell-side analysts anticipate that Curaleaf Holdings, Inc. will post -0.19 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Articles
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
